Expression of SGLT1 and SGLT2 in Breast Cancer and Potential Anticancer Effects of SGLT1 Inhibitors

被引：0

作者：

Tsunokake, Satoko ^{[1
]}

Iwabichi, Erina ^{[2
]}

Miki, Yasuhiro ^{[3
]}

Kanai, Ayako ^{[4
]}

Onodera, Yoshiaki ^{[3
]}

Ishida, Takanori ^{[1
]}

Sasano, Hironobu ^{[3
]}

Suzuki, Takashi ^{[2
,3
,5
]}

机构：

[1] Tohoku Univ, Dept Breast & Endocrine Surg Oncol, Sendai, Miyagi, Japan

[2] Tohoku Univ, Dept Pathol & Histotechnol, Sendai, Miyagi, Japan

[3] Tohoku Univ, Dept Anat Pathol, Sendai, Miyagi, Japan

[4] Hachinohe Municipal Hosp, Dept Breast Surg, Hachinohe, Aomori, Japan

[5] Tohoku Univ Hosp, Dept Pathol, Sendai, Miyagi, Japan

来源：

CANCER SCIENCE | 2024年 / 115卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P-3266

引用

页码：1939 / 1939

页数：1

共 50 条

[41] IMPACT OF TYROSINE KINASES AND INHIBITORS ON SGLT1 ACTIVITY [J].

Kharve, Kshitee Sandeep ;

Shroff, Aayush ;

Cao, Jeiyun ;

Pasquariello, Kyle .

DRUG METABOLISM AND PHARMACOKINETICS, 2025, 61

[42] Adrenal SGLT1 or SGLT2 as predictors of atherosclerosis under chronic stress based on a computer algorithm [J].

Li, Jianyi ;

Meng, Lingbing ;

Wu, Dishan ;

Xu, Hongxuan ;

Hu, Xing ;

Hu, Gaifeng ;

Chen, Yuhui ;

Xu, Jiapei ;

Gong, Tao ;

Liu, Deping .

PEERJ, 2023, 11

[43] Does SGLT1 inhibition add to the benefits of SGLT2 inhibition in the prevention and treatment of heart failure? [J].

Pitt, Bertram ;

Bhatt, Deepak L. ;

Metra, Marco .

EUROPEAN HEART JOURNAL, 2022, 43 (45) :4754-4757

[44] Development of a cell-based nonradioactive glucose uptake assay system for SGLT1 and SGLT2 [J].

Kanwal, Abhinav ;

Singh, Shailendra Pratap ;

Grover, Paramjit ;

Banerjee, Sanjay Kumar .

ANALYTICAL BIOCHEMISTRY, 2012, 429 (01) :70-75

[45] SGLT1 inhibition: Pros and cons [J].

Tsimihodimos, Vasilis ;

Filippas-Ntekouan, Sebastien ;

Elisaf, Moses .

EUROPEAN JOURNAL OF PHARMACOLOGY, 2018, 838 :153-156

[46] Synthesis and biological evaluation of benzocyclobutane-C-glycosides as potent and orally active SGLT1/SGLT2 dual inhibitors [J].

Kuo, Gee-Hong ;

Gaul, Micheal D. ;

Liang, Yin ;

Xu, June Z. ;

Du, Fuyong ;

Hornby, Pamela ;

Xu, Guozhang ;

Qi, Jenson ;

Wallace, Nathaniel ;

Lee, Seunghun ;

Grant, Eugene ;

Murray, William V. ;

Demarest, Keith .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2018, 28 (07) :1182-1187

[47] Comparison of SGLT1, SGLT2, and Dual Inhibitor Biological Activity in Treating Type 2 Diabetes Mellitus [J].

Azizogli, Abdul-Rahman ;

Vitti, Michael R. ;

Mishra, Richa ;

Osorno, Laura ;

Heffernan, Corey ;

Kumar, Vivek A. .

ADVANCED THERAPEUTICS, 2023, 6 (12)

[48] SGLT1 in Pancreatic a Cells Regulates Glucagon Secretion in Mice, Possibly Explaining the Distinct Effects of SGLT2 Inhibitors on Plasma Glucagon Levels [J].

Suga, Takayoshi ;

Kikuchi, Osamu ;

Kobayashi, Masaki ;

Matsui, Sho ;

Hashimoto, Hiromi H. ;

Sasaki, Tsutomu ;

Kakizaki, Satoru ;

Yamada, Masanobu ;

Kitamura, Tadahiro .

DIABETES, 2018, 67

[49] SGLT1: A Potential Drug Target for Cardiovascular Disease [J].

Zhao, Mengnan ;

Li, Na ;

Zhou, Hong .

DRUG DESIGN DEVELOPMENT AND THERAPY, 2023, 17 :2011-2023

[50] SGLT1 in pancreatic α cells regulates glucagon secretion in mice, possibly explaining the distinct effects of SGLT2 inhibitors on plasma glucagon levels [J].

Suga, Takayoshi ;

Kikuchi, Osamu ;

Kobayashi, Masaki ;

Matsui, Sho ;

Yokota-Hashimoto, Hiromi ;

Wada, Eri ;

Kohno, Daisuke ;

Sasaki, Tsutomu ;

Takeuchi, Kazusane ;

Kakizaki, Satoru ;

Yamada, Masanobu ;

Kitamura, Tadahiro .

MOLECULAR METABOLISM, 2019, 19 :1-12

← 1 2 3 4 5 →